Raras
Buscar doenças, sintomas, genes...
Síndrome Rubinstein-Taybi por mutações CREBBP
ORPHA:353277CID-10 · Q87.2OMIM 180849DOENÇA RARA

Síndrome de Rubinstein-Taybi causada por uma mutação no gene CREBBP.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome de Rubinstein-Taybi causada por uma mutação no gene CREBBP.

🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.2
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
19 sintomas
😀
Face
19 sintomas
🧠
Neurológico
15 sintomas
❤️
Coração
15 sintomas
👁️
Olhos
13 sintomas
📏
Crescimento
10 sintomas

+ 81 sintomas em outras categorias

Características mais comuns

100%prev.
Início na infância
Obrigatório (100%)
100%prev.
HP:0003577
Frequência: 6/6
100%prev.
Falange larga do hálux
Obrigatório (100%)
100%prev.
Hemangioma capilar
Obrigatório (100%)
100%prev.
Sobrancelha larga
Frequência: 6/6
100%prev.
Prolapso da valva mitral
Obrigatório (100%)
212sintomas
Muito frequente (61)
Frequente (34)
Ocasional (53)
Muito raro (17)
Sem dados (47)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 212 características clínicas mais associadas, ordenadas por frequência.

Início na infânciaInfantile onset
Obrigatório (100%)100%
HP:0003577
Frequência: 6/6100%
Falange larga do háluxBroad hallux phalanx
Obrigatório (100%)100%
Hemangioma capilarCapillary hemangioma
Obrigatório (100%)100%
Sobrancelha largaBroad eyebrow
Frequência: 6/6100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos116publicações
Pico201616 papers
Linha do tempo
2026Hoje · 2026📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

Autosomal dominant
CREBBPCREB-binding proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acetylates histones, giving a specific tag for transcriptional activation (PubMed:21131905, PubMed:24616510). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905). Also acetylates non-histone proteins, like DDX21, FBL, IRF2, MAFG, NCOA3, POLR1E/PAF53 and FOXO1 (PubMed:10490106, PubMed:11154691, PubMed:12738767, PubMed:12929931, PubMed:24207024, PubMed:28790157, PubMed:30540930, PubMed:35675826, PubMed:9707565). Binds specifically to ph

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
SARS-CoV-2 activates/modulates innate and adaptive immune responses
EXPRESSÃO TECIDUAL(Ubíquo)
Útero
53.4 TPM
Ovário
49.6 TPM
Cervix Endocervix
48.1 TPM
Cerebelo
45.0 TPM
Artéria tibial
41.8 TPM
OUTRAS DOENÇAS (5)
Menke-Hennekam syndrome 1Rubinstein-Taybi syndrome due to CREBBP mutationsMenke-Hennekam syndromeacute myeloid leukemia with t(8;16)(p11;p13) translocation
HGNC:2348UniProt:Q92793
EP300Histone acetyltransferase p300MENDELIANAltamente restrito
FUNÇÃO

Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:40240600, PubMed:8945521). Acetylates all four core histones in nucleosomes (PubMed:23415232, PubMed:23934153, PubMed:8945521). Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of t

LOCALIZAÇÃO

CytoplasmNucleusChromosome

VIAS BIOLÓGICAS (10)
Regulation of RUNX3 expression and activityRegulation of FOXO transcriptional activity by acetylationHATs acetylate histonesSTAT3 nuclear events downstream of ALK signalingAttenuation phase
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
49.5 TPM
Cerebelo
47.8 TPM
Útero
45.1 TPM
Ovário
45.1 TPM
Cervix Endocervix
42.9 TPM
OUTRAS DOENÇAS (3)
Menke-Hennekam syndrome 2colorectal cancerRubinstein-Taybi syndrome due to EP300 haploinsufficiency
HGNC:3373UniProt:Q09472

Variantes genéticas (ClinVar)

963 variantes patogênicas registradas no ClinVar.

🧬 CREBBP: NM_004380.3(CREBBP):c.1340G>A (p.Gly447Glu) ()
🧬 CREBBP: NM_004380.3(CREBBP):c.1063_1064del (p.Gln355fs) ()
🧬 CREBBP: NM_004380.3(CREBBP):c.966del (p.Pro323fs) ()
🧬 CREBBP: NM_004380.3(CREBBP):c.1923del (p.Met640_Tyr641insTer) ()
🧬 CREBBP: NM_004380.3(CREBBP):c.2925del (p.Ser976fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 718 variantes classificadas pelo ClinVar.

359
251
108
Patogênica (50.0%)
VUS (35.0%)
Benigna (15.0%)
VARIANTES MAIS SIGNIFICATIVAS
CREBBP: NM_004380.3(CREBBP):c.4369dup (p.Tyr1457fs) [Pathogenic]
CREBBP: NM_004380.3(CREBBP):c.4154T>A (p.Met1385Lys) [Likely pathogenic]
CREBBP: NM_004380.3(CREBBP):c.85+1G>C [Likely pathogenic]
CREBBP: NM_004380.3(CREBBP):c.4648_4660del (p.Glu1550fs) [Likely pathogenic]
CREBBP: NM_004380.3(CREBBP):c.840del (p.Phe280fs) [Likely pathogenic]

Vias biológicas (Reactome)

43 vias biológicas associadas aos genes desta condição.

Regulation of gene expression by Hypoxia-inducible Factor BMAL1:CLOCK,NPAS2 activates circadian expression Pre-NOTCH Transcription and Translation PPARA activates gene expression Formation of the beta-catenin:TCF transactivating complex Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells NOTCH1 Intracellular Domain Regulates Transcription Transcriptional activation of mitochondrial biogenesis Activation of gene expression by SREBF (SREBP) Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production HATs acetylate histones Attenuation phase Notch-HLH transcription pathway Transcriptional regulation of white adipocyte differentiation SUMOylation of transcription cofactors Regulation of lipid metabolism by PPARalpha Activation of anterior HOX genes in hindbrain development during early embryogenesis CD209 (DC-SIGN) signaling TP53 Regulates Transcription of Genes Involved in Cytochrome C Release Activation of the TFAP2 (AP-2) family of transcription factors RUNX1 regulates transcription of genes involved in differentiation of myeloid cells RUNX3 regulates NOTCH signaling NOTCH3 Intracellular Domain Regulates Transcription NOTCH4 Intracellular Domain Regulates Transcription Estrogen-dependent gene expression TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation FOXO-mediated transcription of cell death genes Polo-like kinase mediated events SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription NOTCH2 intracellular domain regulates transcription B-WICH complex positively regulates rRNA expression Metalloprotease DUBs TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Methylation PI5P Regulates TP53 Acetylation RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known Regulation of RUNX3 expression and activity RUNX3 regulates p14-ARF

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Rubinstein-Taybi por mutações CREBBP

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics2026 Feb 23

Rubinstein-Taybi syndrome (RSTS) and Menke-Hennekam syndrome (MKHK) are two rare Mendelian disorders presented with variable degrees of intellectual disability and different facial dysmorphism. They are caused by loss-of-function (LOF) variants or missense/inframe deletion variants in the exon 30 and 31 of the CREBBP gene respectively. This study aimed to refine the phenotype and provide characterization of genome-wide DNA methylation (DNAm) in RSTS and MKHK. We integrated and analyzed clinical data of 151 patients with RSTS and 36 patients with MKHK from this study and literatures. Meanwhile, genome-wide DNAm analysis were carried out on 51 blood samples (RSTS n = 9, MKHK n = 8, control n = 33), and 21 human induced pluripotent cell (hiPSC) samples (RSTS n = 5, MKHK n = 4, control n = 12). Phenotype analysis showed that patients with RSTS variants downstream the last 50 nt of the penultimate exon had atypical facial malformation and severer medical problems compared to the classical RSTS caused by LOF CREBBP variants. Individuals with MKHK variants in intrinsically disordered region (IDR) showed resemblant features. Meanwhile, DNAm analysis identified two specific blood DNA methylation patterns (episignatures): RSTS and MKHK_IDR compared to matched normal controls. Samples with MKHK variants outside the IDR did not obey the MKHK_IDR episignature. By interrogating DNAm in hiPSCs of patients with RSTS and MKHK, we observed differentially methylated genes play a role in embryonic development and organogenesis. In conclusion, our results suggest that phenotypic features and DNA methylation episignatures may differ for each genomic region.

#2

Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.

Journal of neuropathology and experimental neurology2025 Apr 01

Rubinstein-Taybi syndrome (RTS) is a congenital disorder with characteristic clinical manifestations. In the vast majority of cases, it is caused by mutations of the gene encoding the transcriptional co-activator cAMP-response element binding protein (CBP)-binding protein (CREBBP). It has been thought to be a tumor predisposition syndrome as RTS patients have an increased risk of developing tumors including meningiomas. However, RTS-associated meningiomas are rarely reported. We report a unique RTS-associated meningioma in which an oncogenic CREBBP mutation is identified. We also comprehensively review the reported RTS-associated meningiomas, from epidemiology and pathogenesis to clinicopathological characteristics and treatment. All RTS patients with meningiomas are female and have the exclusive mutations of CREBBP. In population-based studies RTS-associated meningiomas seem to develop at younger ages. Their pathogenesis may be driven by the CREBBP/CBP alterations resulting in aberrant signal transduction in the CBP-mediated signaling pathways. Meningiomas in RTS patients have common clinicopathological characteristics including comorbidity with other tumors, radiologically intra-osseous growth, and uncommon histopathology such as ossifying and secretory features. Given the genetic nature and rarity of RTS-associated meningiomas, further investigation of their characteristics may define molecular targets for improved therapeutic options for RTS patients.

#3

Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations.

Clinical genetics2025 Mar

Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder linked to haploinsufficiency of CREBBP (RSTS1) and EP300 (RSTS2) genes. Characteristic features often include distinctive facial traits, broad thumbs and toes, short stature, and various degrees of intellectual disability. The clinical presentation of RSTS is notably variable, making it challenging to establish a clear genotype-phenotype correlation, except for specific variants which cause the allelic Menke-Hennekam syndrome. Trio exome analysis, data collection via networking and GeneMatcher platforms, transcript processing analysis, and DNA methylation profiling were performed. We identified two unrelated patients with de novo variants in EP300 (NM_001429.4: c.3671+5G>C; c.3671+5_3671+8delGTAA) predicted to cause in-frame exon 20 skipping, confirmed in one patient. In silico 3D protein modeling suggested that exon 20 deletion (comprising 27 amino acids) likely alters the structural conformation between the RING_CBP-p300 and HAT-KAT11 domains. Clinically, both patients displayed severe RSTS2-like clinical features, including autism spectrum disorder, speech delay, hearing loss, microcephaly, developmental delay, and intellectual disability, alongside ocular, respiratory, and cardiovascular abnormalities. Additionally, one patient developed early-onset colorectal cancer. DNA methylation profiling in Subject #1 confirmed RSTS but did not align with the specific episignatures for RSTS1 or RSTS2. We propose that skipping of exon 20 in EP300 is associated with a distinct form of Rubinstein-Taybi syndrome featuring clinical characteristics not fully aligning with RSTS1 or RSTS2. Our findings increase the understanding of RSTS genetic and molecular basis and stress the need for further research to establish definitive genotype-phenotype correlations.

#4

Dilated cardiomyopathy in Rubinstein-Taybi syndrome: A case report and mini-review of the literature.

Medicine international2025

Rubinstein-Taybi syndrome (RTS) or Broad Thumb-Hallux syndrome, is a rare neurodevelopmental disorder characterized by distinctive physical, cognitive and congenital abnormalities. Mutations in the CREBBP or EP300 genes are implicated, often arising de novo. While cardiac defects are noted in 32.6% of patients with RTS, the association with dilated cardiomyopathy (DCM) remains poorly explored. The present study describes a clinically diagnosed case of a 32-year-old male patient with RTS, manifesting with symptoms of heart failure. The patient, born to a consanguineous marriage, exhibited hallmark features of RTS, including short stature, dysmorphic facial features, intellectual disability and broad thumbs. DCM was confirmed by echocardiography with an ejection fraction of 20%. The patient responded well to diuretics for heart failure and was referred for specialized cardiology and surgical management. Cardiac manifestations in RTS vary from septal defects to complex anomalies, with few reports on DCM. The genetic basis of RTS may contribute to cardiac dysfunction, underscoring the need for multidisciplinary care. The case described herein highlights the necessity of recognizing RTS in adults with unexplained syndromic features and cardiac symptoms. Comprehensive evaluation, including cardiac screening, is essential for improving patient outcomes. Further research is warranted to establish the link between RTS and DCM and to develop diagnostic and therapeutic guidelines.

#5

A Novel Intragenic Duplication of CREBBP in Rubinstein-Taybi Syndrome: A Case Report Expanding the Genotype-Phenotype Spectrum.

Molecular syndromology2025 Aug 21

Rubinstein-Taybi syndrome (RSTS) is most often caused by loss-of-function variants in CREBBP; intragenic duplications are rare and extremely under-recognized. We describe a 5-year-old girl with global developmental delay, intellectual disability, frontal bossing, upslanted palpebral fissures, broad angulated halluces, and scoliosis. Whole-exome sequencing with copy number analysis revealed a heterozygous de novo duplication of approximately 13 kb encompassing exons 7-16 of CREBBP (NM_004380.3). Multiplex ligation-dependent probe amplification confirmed the duplication in the proband and excluded it in both parents. The event is predicted to introduce a frameshift, leading to premature truncation. No additional pathogenic variants were detected. This is the first reported CREBBP duplication spanning exons 7-16, expanding the mutational spectrum of RSTS and illustrating that intragenic duplications can manifest with a partially atypical craniofacial profile. The case underscores the value of incorporating high-resolution copy number interrogation into RSTS workflows when single nucleotide variant analysis is uninformative and supports systematic deposition of such variants to refine genotype-phenotype correlations.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 115

2026

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics
2025

Dilated cardiomyopathy in Rubinstein-Taybi syndrome: A case report and mini-review of the literature.

Medicine international
2025

A Novel Intragenic Duplication of CREBBP in Rubinstein-Taybi Syndrome: A Case Report Expanding the Genotype-Phenotype Spectrum.

Molecular syndromology
2025

Genomic Sequencing Insights Into a Rare Case of High-Risk Diffuse Large B-cell Lymphoma (DLBCL) Associated With Rubinstein-Taybi Syndrome.

Cureus
2025

Clinical and Genetic Management of a Patient with Rubinstein-Taybi Syndrome Type 1: A Case Report.

Genes
2025

A 261 kb deletion spanning three genes is causing Rubinstein-Taybi syndrome type 1 in a 6-year-old boy belonging to Kashmir valley, India.

Gene
2025

Further Delineation of the AUTS2 HX Repeat Domain-Related Phenotype.

American journal of medical genetics. Part A
2025

Brain Abnormalities in Prenatally Diagnosed Rubinstein-Taybi Syndrome.

Prenatal diagnosis
2025

Report of Hidradenitis Suppurativa in an Individual Affected by Rubinstein-Taybi Syndrome.

Pediatric dermatology
2025

A New EP300 -Related Syndrome With Prominent Developmental and Immune Phenotypes.

American journal of medical genetics. Part A
2025

Exudative retinal detachment in a pediatric patient with Rubinstein-Taybi syndrome.

Retinal cases & brief reports
2025

Identification of de-novo CREBBP gene variants in patients with Rubinstein-Taybi syndrome.

Psychiatric genetics
2025

Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.

Journal of neuropathology and experimental neurology
2025

Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations.

Clinical genetics
2024

Transcriptome and acetylome profiling identify crucial steps of neuronal differentiation in Rubinstein-Taybi syndrome.

Communications biology
2024

[Prenatal diagnosis of a fetus with Rubinstein-Taybi syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

The Phenotype-Based Approach Can Solve Cold Cases: The Paradigm of Mosaic Mutations of the CREBBP Gene.

Genes
2024

Generation of an induced pluripotent stem cell line IGIBi18-A from an Indian patient with Rubinstein Taybi Syndrome.

Stem cell research
2024

A case report on Rubinsein-Taybi syndrome associated with a de novo CREBBP gene mutation.

Asian journal of surgery
2024

Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles.

HGG advances
2024

[Clinical and genetic characteristics of 21 children with Rubinstein-Taybi syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.

Journal of medical genetics
2023

The relationship between neurodevelopmental transcriptional programs and insomnia: From Rubinstein-Taybi syndrome into energy metabolism.

Sleep medicine
2024

Molecular insight into CREBBP and TANGO2 variants causing intellectual disability.

The journal of gene medicine
2023

EP300 facilitates human trophoblast stem cell differentiation.

Proceedings of the National Academy of Sciences of the United States of America
2023

Diagnosis of Menke-Hennekam syndrome by prenatal whole exome sequencing and review of prenatal signs.

Molecular genetics & genomic medicine
2023

Dermatological findings in Rubinstein-Taybi Syndrome.

Italian journal of dermatology and venereology
2023

Novel heterozygous variants in the EP300 gene cause Rubinstein-Taybi syndrome 2: Reports from two Chinese children.

Molecular genetics & genomic medicine
2023

De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia.

BMC medical genomics
2024

Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome - A case report and review of literature.

Ophthalmic genetics
2023

Case report: A preterm infant with rubinstein-taybi syndrome and Marmorata telangiectatica harboring a frameshift mutation in the CREBBP gene.

Frontiers in pediatrics
2023

Case report: a Chinese girl like atypical Rubinstein-Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene.

BMC medical genomics
2023

Congenital glaucoma as a presenting feature of Rubinstein-Taybi syndrome in an infant with a novel pathogenic variant in the CREBBP gene.

BMJ case reports
2023

High molecular diagnostic yields and novel phenotypic expansions involving syndromic anorectal malformations.

European journal of human genetics : EJHG
2022

A novel CREBBP mutation and its phenotype in a case of Rubinstein-Taybi syndrome.

BMC medical genomics
2022

Menke-Hennekam Syndrome: A Literature Review and a New Case Report.

Children (Basel, Switzerland)
2022

Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome.

Pediatric hematology and oncology
2022

Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype.

American journal of medical genetics. Part A
2022

Divergent variant patterns among 19 patients with Rubinstein-Taybi syndrome uncovered by comprehensive genetic analysis including whole genome sequencing.

Clinical genetics
2021

Rubinstein-Taybi syndrome: a rare case report of a female child emphasizing physiotherapy on gross motor function.

The Pan African medical journal
2021

Clinical description and mutational profile of a Moroccan series of patients with Rubinstein Taybi syndrome.

African health sciences
2021

NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.

Molecular cell
2022

Interstitial lung disease in children with Rubinstein-Taybi syndrome.

Pediatric pulmonology
2021

Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.

Molecular genetics & genomic medicine
2021

Identification of de novo EP300 and PLAU variants in a patient with Rubinstein-Taybi syndrome-related arterial vasculopathy and skeletal anomaly.

Scientific reports
2021

CHARGE syndrome and related disorders: a mechanistic link.

Human molecular genetics
2021

Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Genes
2022

Genes for RNA-binding proteins involved in neural-specific functions and diseases are downregulated in Rubinstein-Taybi iNeurons.

Neural regeneration research
2021

Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients.

International journal of molecular sciences
2021

Novel Findings in Floating-Harbor Syndrome and a Mini-Review of the Literature.

Molecular syndromology
2021

A clinical characteristics and genetic analysis of a case of Rubinstein-Taybi syndrome with glaucoma.

European review for medical and pharmacological sciences
2021

CREB-binding protein (CREBBP) and preeclampsia: a new promising target gene.

Molecular biology reports
2021

Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.

American journal of medical genetics. Part A
2021

Rubinstein-Taybi syndrome in Chinese population with four novel mutations.

American journal of medical genetics. Part A
2020

EP300-related Rubinstein-Taybi syndrome: Highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients.

American journal of medical genetics. Part A
2020

Rubinstein-Taybi syndrome in diverse populations.

American journal of medical genetics. Part A
2021

A Novel CREBBP in-Frame Deletion Variant in a Chinese Girl with Atypical Rubinstein-Taybi Syndrome Phenotypes.

Journal of molecular neuroscience : MN
2020

Screening of a large Rubinstein-Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain.

American journal of medical genetics. Part A
2021

Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.

European journal of human genetics : EJHG
2020

Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome Patients.

Journal of clinical immunology
2020

Transcriptome Analysis of iPSC-Derived Neurons from Rubinstein-Taybi Patients Reveals Deficits in Neuronal Differentiation.

Molecular neurobiology
2020

CREBBP gene mutation in an infant with Rubinstein-Taybi syndrome.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2020

Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome.

Orphanet journal of rare diseases
2020

Chromosome 16p13.3 Contiguous Gene Deletion Syndrome including the SLX4, DNASE1, TRAP1, and CREBBP Genes Presenting as a Relatively Mild Rubinstein-Taybi Syndrome Phenotype: A Case Report of a Saudi Boy.

Case reports in genetics
2019

The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.

Acta neuropathologica communications
2019

Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.

Molecular genetics & genomic medicine
2019

New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients.

Molecular genetics & genomic medicine
2019

[Clinical and genetic analysis of two cases with Rubinstein-Taybi syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2020

Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells.

Carcinogenesis
2019

Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations.

Stem cell research
2019

Tissue-specific mosaicism in a patient with Rubinstein-Taybi syndrome and CREBBP exon 1 duplication.

Clinical dysmorphology
2019

Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP.

American journal of medical genetics. Part A
2019

Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.

Human genetics
2019

Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.

Clinical dysmorphology
2019

Next generation sequencing identified two novel mutations in NIPBL and a frame shift mutation in CREBBP in three Chinese children.

Orphanet journal of rare diseases
2019

Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP.

American journal of medical genetics. Part A
2019

Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.

BMC medical genetics
2019

Fetal phenotype of Rubinstein-Taybi syndrome caused by CREBBP mutations.

Clinical genetics
2019

First case of Rubinstein-Taybi syndrome with desquamation associated with a novel mutation in the bromodomain of the CREBBP gene.

Clinical and experimental dermatology
2018

Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*).

Stem cell research
2018

iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.

Stem cell research
2018

Rubinstein-Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2018

Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.

Developmental cell
2018

Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.

BMC medical genetics
2018

Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.

American journal of medical genetics. Part A
2018

Perthes disease: A new finding in Floating-Harbor syndrome.

American journal of medical genetics. Part A
2018

Benign and malignant tumors in Rubinstein-Taybi syndrome.

American journal of medical genetics. Part A
2017

[Clinical features of Rubinstein-Taybi syndrome and novel mutation in the CREBBP gene: an analysis of one case].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2017

Rubinstein-Taybi Syndrome and Epigenetic Alterations.

Advances in experimental medicine and biology
2017

A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene.

The Turkish journal of pediatrics
2016

First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.

BMC medical genetics
2016

Coffin-Siris syndrome with café-au-lait spots, obesity and hyperinsulinism caused by a mutation in the ARID1B gene.

Intractable & rare diseases research
2016

Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.

American journal of medical genetics. Part A
2015

Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Journal of pediatric genetics
2016

Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.

Clinical dysmorphology
2016

Whole exome sequencing reveals EP300 mutation in mildly affected female: expansion of the spectrum.

Clinical case reports
2016

Rubinstein-Taybi syndrome with multiple pilomatricomas: The first case diagnosed by CREBBP mutation analysis.

Journal of dermatological science
2016

CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.

American journal of medical genetics. Part A
2016

Analysis of mutations within the intron20 splice donor site of CREBBP in patients with and without classical RSTS.

European journal of human genetics : EJHG
2016

Rubinstein-Taybi syndrome - a window into follicular lymphoma biology.

Leukemia & lymphoma
2016

Mosaic CREBBP mutation causes overlapping clinical features of Rubinstein-Taybi and Filippi syndromes.

European journal of human genetics : EJHG
2016

Maternally inherited autosomal dominant intellectual disability caused by 16p13.3 microduplication.

European journal of medical genetics
2016

CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein-Taybi syndrome.

Molecular genetics & genomic medicine
2016

Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.

PloS one
2015

Rubinstein-Taybi Syndrome in a 19-years old boy.

Neuro endocrinology letters
2016

Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report.

Human pathology
2015

Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry.

Scientific reports
2016

From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.

Human mutation
2016

Hepatoblastoma in Rubinstein-Taybi Syndrome: A Case Report.

Pediatric blood & cancer
2015

Meta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to Preeclampsia.

PloS one
2015

Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.

Human genetics
2015

Whole exome sequencing for a patient with Rubinstein-Taybi syndrome reveals de novo variants besides an overt CREBBP mutation.

International journal of molecular sciences
2015

Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome.

American journal of medical genetics. Part A
2015

A case of Rubinstein-Taybi syndrome associated with growth hormone deficiency in childhood.

Clinical endocrinology
2015

Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Italian journal of pediatrics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Rubinstein-Taybi por mutações CREBBP.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Rubinstein-Taybi por mutações CREBBP

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.
    Human molecular genetics· 2026· PMID 41758603mais citado
  2. Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.
    Journal of neuropathology and experimental neurology· 2025· PMID 39740655mais citado
  3. Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations.
    Clinical genetics· 2025· PMID 39603792mais citado
  4. Dilated cardiomyopathy in Rubinstein-Taybi syndrome: A case report and mini-review of the literature.
    Medicine international· 2025· PMID 41221257mais citado
  5. A Novel Intragenic Duplication of CREBBP in Rubinstein-Taybi Syndrome: A Case Report Expanding the Genotype-Phenotype Spectrum.
    Molecular syndromology· 2025· PMID 41064057mais citado
  6. Profiles of autism characteristics in thirteen genetic syndromes: a machine learning approach.
    Mol Autism· 2023· PMID 36639821recente
  7. Syndromes associated with multiple pilomatricomas: When should clinicians be concerned?
    Pediatr Dermatol· 2020· PMID 31618803recente
  8. Genotype-phenotype specificity in Menke-Hennekam syndrome caused by missense variants in exon 30 or 31 of CREBBP.
    Am J Med Genet A· 2019· PMID 30892814recente
  9. Main genetic entities associated with supernumerary teeth.
    Arch Argent Pediatr· 2018· PMID 30457727recente
  10. Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease.
    Neurosurgery· 2018· PMID 29660026recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:353277(Orphanet)
  2. OMIM OMIM:180849(OMIM)
  3. MONDO:0008393(MONDO)
  4. GARD:17534(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Rubinstein-Taybi por mutações CREBBP
Compêndio · Raras BR

Síndrome Rubinstein-Taybi por mutações CREBBP

ORPHA:353277 · MONDO:0008393
CID-10
Q87.2 · Síndromes com malformações congênitas afetando predominantemente os membros
Início
Antenatal, Neonatal
MedGen
UMLS
C5681840
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades